High platelet content can increase storage lesion rates following Intercept pathogen inactivation primarily in platelet concentrates prepared by apheresis

Psoralen and Ultraviolet A Light Treatment Directly Affects Phosphatidylinositol 3-Kinase Signal Transduction by Altering Plasma Membrane Packing

(2016) Britt Van Aelst et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Experiences with semi-routine production of riboflavin and UV-B pathogen-inactivated platelet concentrates in three blood centres

(2016) P. F. van der Meer et al.   VOX SANGUINIS

Riboflavin and amotosalen photochemical treatments of platelet concentrates reduce thrombus formation kineticsin vitro

(2014) B. Van Aelst et al.   VOX SANGUINIS

Pathogen Inactivation of Platelet and Plasma Blood Components for Transfusion Using the INTERCEPT Blood SystemTM

(2011) Johannes Irsch et al.   TRANSFUSION MEDICINE AND HEMOTHERAPY

In vitro assessment of apheresis and pooled buffy coat platelet components suspended in plasma and SSP+ photochemically treated with amotosalen and UVA for pathogen inactivation (INTERCEPT Blood System™)

(2010) P. Chavarin et al.   VOX SANGUINIS

Function and activation state of platelets in vitro depend on apheresis modality

(2010) S. Macher et al.   VOX SANGUINIS

Evaluation of in vitro storage properties of prestorage pooled whole blood-derived platelets suspended in 100 percent plasma and treated with amotosalen and long-wavelength ultraviolet light

(2009) Stephen J. Wagner et al.   TRANSFUSION

Cell integrity and mitochondrial function after Mirasol-PRT treatment for pathogen reduction of apheresis-derived platelets: Results of a three-arm in vitro study

(2009) Susanne M. Picker et al.   TRANSFUSION AND APHERESIS SCIENCE

Functional characteristics of apheresis-derived platelets treated with ultraviolet light combined with either amotosalen-HCl (S-59) or riboflavin (vitamin B2) for pathogen-reduction

(2009) S. M. Picker et al.   VOX SANGUINIS